Procter & Gamble Stake Slashed 18.9%; UBS Retains $161 Buy Rating
Procter & Gamble shares are up 12% year-to-date despite a 5.8% drop and a Hold rating from TD Cowen, while UBS keeps a $161 Buy target. Twin Capital cut its stake by 18.9% (11,593 shares) and Michigan’s retirement system trimmed its holding by 0.6% to 657,137 shares.
1. Analyst Ratings and Price Targets
In late January, TD Cowen downgraded Procter & Gamble shares from Buy to Hold and raised its price target to $156 from $150, citing growth contingent on regaining market share. In mid-January, UBS reaffirmed its Buy rating with a $161 target, noting investor division over whether growth pressures are cyclical or structural.
2. Share Performance Trends
Despite a 5.8% decline over the past year, P&G shares have rallied 12% year-to-date, reflecting resilience in core consumer goods demand. Commentary highlighted that even after an acknowledged weak quarter, the stock’s consistency has driven sustained gains, underscoring market confidence in long-term stability.
3. Institutional Holdings Adjustments
Twin Capital Management reduced its P&G stake by 18.9%, selling 11,593 shares and leaving 49,622 shares on its books. Meanwhile, the State of Michigan Retirement System trimmed its position by 0.6%, lowering its holding to 657,137 shares, reflecting modest portfolio rebalancing among institutional investors.